| Literature DB >> 34484725 |
Dilasma Ghartimagar1, Adarsh Kumar Jhunjhunwala1, Arnab Ghosh1, Manish Kiran Shrestha2.
Abstract
INTRODUCTION: The density of gallbladder carcinoma differs in different parts of the world. It is an aggressive tumor with poor prognosis presenting in advanced stages due to paucity of signs and symptoms. This research was conducted to analyze the frequency of incidental and clinically suspected gallbladder carcinoma with clinicopathological correlation.Entities:
Keywords: Carcinoma; Clinically suspected; Gallbladder; Gallstone; Incidental
Year: 2021 PMID: 34484725 PMCID: PMC8405908 DOI: 10.1016/j.amsu.2021.102753
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Distribution of all gallbladder carcinoma cases with respect to gender (n = 35).
| Diagnosis | Gender | Total n (%) | ||
|---|---|---|---|---|
| Male n (%) | Female n (%) | |||
| Gallbladder carcinoma | Incidental carcinoma | 9 (34.61) | 17 (65.38) | 26 (74.28) |
| Clinically suspected carcinoma | 2 (22.22) | 7 (77.77) | 9 (25.71) | |
| Total | 11 (31.42) | 24 (68.57) | 35 (100) | |
Distribution of all gallbladder carcinoma cases in different age groups.
| Diagnosis | Age-group (years) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 21–30 | 31–40 | 41–50 | 51–60 | 61–70 | 71–80 | Total | Mean age (years) | ||
| Gallbladder carcinoma | Incidental carcinoma | 1 | – | 8 | 6 | 9 | 2 | 27 | 55.53 ± 11.58 |
| Clinically suspected carcinoma | – | 1 | 1 | 2 | 5 | – | 9 | 59.33 ± 10.93 | |
| Total | 1 | 1 | 9 | 8 | 14 | 2 | 35 | 56.51 ± 11.38 | |
Association of gallbladder carcinoma with gallstones (n = 35).
| Diagnosis | Frequency (n) | Percentage (%) | |||
|---|---|---|---|---|---|
| Gallbladder carcinoma | Incidental carcinoma | with gallstone | 14 | 26 | 74.28 |
| without gallstone | 12 | ||||
| Clinically suspected carcinoma | with gallstone | 1 | 9 | 25.71 | |
| without gallstone | 8 | ||||
Diagnostic correlation with clinical diagnosis, microscopic findings and tumor staging in incidental carcinoma cases (n = 26).
| Diagnosis | No of cases | Clinical Diagnosis | Microscopic Findings | Tumor staging | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cholelithiasis | Chronic cholecystitis | Acute cholecystitis | Empyema | Obstructive Jaundice | L. Emboli | PNI | Margin positive | Omental Deposit | T1 | T2 | T3 | |||||
| T 1a | T 1b | T 2a | T 2b | |||||||||||||
| Adenocarcinoma | Well differentiated | 19 | 14 | 2 | 3 | – | – | – | 4 | – | – | 2 | 9 | – | 6 | 2 |
| Moderately differentiated | 7 | – | 4 | – | 2 | 1 | 1 | – | 3 | 1 | – | – | – | 5 | 2 | |
| Total Incidental Carcinoma | 26 | 14 | 6 | 3 | 2 | 1 | 1 | 4 | 3 | 1 | 2 | 9 | – | 11 | 4 | |
PNI - Perineural infiltration, L. Emboli- Lymphatic Emboli.
Correlation of gallbladder size and gallbladder wall thickness in incidental carcinoma cases (n = 26).
| Diagnosis | GB size | Wall thickness | ||
|---|---|---|---|---|
| Range | Mean | Range | Mean | |
| Well differentiated adenocarcinoma | 5–9 | 6.2 ± 1.367 | 0.2–2 | 0.6474 ± 0.537 |
| Moderately differentiated adenocarcinoma | 6.3–9.5 | 8.54 ± 1.08 | 0.2–1 | 0.571 ± 0.534 |
| Total Incidental Carcinoma | 5–9.5 | 6.87 ± 1.64 | 0.2–2.0 | 0.62 ± 0.52 |
Diagnostic correlation with clinical diagnosis, radiological and pathological findings in clinically suspected carcinoma (n = 9).
| Diagnosis | No of cases | Clinical Diagnosis | Radiological Findings | Gross Findings | Microscopic Findings | Tumor staging | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cholelithiasis | Chronic cholecystitis | Obst Jaundice | Rt lobe liver infil tration | CBD | Pancreas | GB size (cm) | Wall thickness (cm) | Tumor size (cm) | L. Emboli | PNI | Margin positive | LN positive | T1 | T2 | T3 | |||||||||
| Range | Mean | Range | Mean | Range | Mean | T1a | T1b | T2a | T2b | |||||||||||||||
| Adenocarcinoma | Well differentiated | 4 | 1 | 3 | – | 1 | 1 | 6–9 | 8.1 ± 1.43 | 0.2–0.5 | 0.37 ± 0.15 | 0.2–3.8 | 2.07 ± 1.68 | – | – | 1 | – | 1 | 1 | 1 | – | 1 | ||
| Poorly differentiated | 2 | – | 2 | – | 1 | 1 | 1 | 5–9 | 7 ± 2.82 | 0.5–1.3 | 0.9 ± 0.56 | 1.3–6 | 3.65 ± 3.3 | 1 | 1 | 1 | – | – | – | – | 1 | 1 | ||
| Mucin secreting | 2 | – | 1 | 1 | – | 6–9 | 7.5 ± 2.12 | 0.3–0.7 | 0.5 ± 0.28 | 1.5–4 | 2.75 ± 1.76 | 1 | – | – | 1 | – | – | – | 1 | 1 | ||||
| Adenosquamous Carcinoma | 1 | – | 1 | – | – | 1 | 9 | 9 | 0.2 | 0.2 | 0.2 | 0.2 | – | – | 1 | – | – | – | – | 1 | – | |||
| Total | 9 | 1 | 7 | 1 | 2 | 3 | 1 | 5–9 | 7.83 ± 1.65 | 0.2–1.3 | 0.5 ± 0.34 | 0.2–6 | 2.3 ± 1.97 | 2 | 1 | 3 | 1 | 1 | 1 | 1 | 3 | 3 | ||
CBD- Common bile duct, L. Emboli- Lymphatic Emboli, PNI – Perineural infiltration, LN – Lymphnode.